1.Pharmacological Treatments of Behavioral Symptoms in Dementia.
Journal of the Korean Medical Association 2002;45(4):415-420
Behavioral symptoms are well-recognized concomitants of the progression of dementia. These symptoms include agitation, aggression, anxiety, depression, disinhibition, delusions, hallucination, and sleep disturbance. Because these symptoms are a major source of impaired quality of life for patients and their caregivers, appropriate pharmacological management of them may reduce the burden of caregivers and postpone institutionalization. Furthermore, behavioral symptoms may be more amenable to pharmacological intervention than cognitive symptoms. For that reason, detailed evaluation and appropriate treatment are the mainstay in the management of dementia patients. In this article, we reviewed symptomatology and psychopharmacology for behavioral symptoms of dementia.
Aggression
;
Alzheimer Disease
;
Anxiety
;
Behavioral Symptoms*
;
Caregivers
;
Delusions
;
Dementia*
;
Depression
;
Dihydroergotamine
;
Hallucinations
;
Humans
;
Institutionalization
;
Neurobehavioral Manifestations
;
Psychopharmacology
;
Quality of Life
2.Bone Mineral Density in Well Controlled IDDM.
Dong Woon SHIN ; Heon Seok HAN
Journal of Korean Society of Pediatric Endocrinology 1997;2(1):116-121
PURPOSE:Effects of IDDM on bone mineral metabolism are still in controversy. Some reported that bone mineral density in IDDM had inverse relationship with HbA1c, some reported that spine BMD was normal while femur BMD was decreased. Others reported that increased urinary calcium excretion in IDDM induced early trabecular bone mineral loss. We studied the correlation of BMD with diabetic control and body measurements. METHODS:In sixteen IDDM patients, using dual energy X-ray absorptiometry, BMD was measured in lumbar spine as trabecular bone and femur neck as cortical bone. Z-score of BMD was obtained by comparing age and sex matched control data. Correlations between BMD and diabetic control parameters (HbA1c, duration of IDDM) and body measurements were calculated. RESULTS:The body measurements were in normal range in all IDDM patients, the duration of IDDM was 38.4+/-24.0months, HbA1c was in good control state (7.69+/-1.53%), and urinary Ca/creatinine ratio was not increased. The Z-score of BMD was not decreased statistically (lumbar spine: -0.255, femur neck: -0.404), and the Z-score had no correlationship with body measurements and diabetic control parameters. CONCLUSIONS:In well controlled childhood IDDM, BMD was not decreased significantly.
Absorptiometry, Photon
;
Bone Density*
;
Calcium
;
Diabetes Mellitus, Type 1*
;
Femur
;
Femur Neck
;
Humans
;
Metabolism
;
Reference Values
;
Spine
3.Asymptomatic uncemented total hip repalacement (changes in the femur) : Natural history determined using Tc-99m MDP bone scan (II).
Chang Dong HAN ; Jin Seok SEO ; Dong Wha LEE
The Journal of the Korean Orthopaedic Association 1993;28(2):513-526
No abstract available.
Hip*
;
Natural History*
;
Technetium Tc 99m Medronate*
4.A Case of Plexiform Neurofibroma of the Right Upper Eyelid and Orbit in Neurofibromatosis.
Dong Seok KIM ; Sang Won KIM ; Han Ik BAE
Korean Journal of Dermatology 1986;24(5):734-738
We have experienced a case of plexiform neurofibrorna of the right upper eyelid and orbit in a 12-year-old girl who had typical skin features of neurofibromatosis and no family history. The non-pulsating proptosis of the right eye and diffuse thickening with hypertrophy of the upper lid, had increased insiduciusly since the birth on. Biopsy taken from eyelirl lesion showed the features of plexiform neurofibroma. Skull X-ray and brain computerized tomogram showed that the right orbit was wider, with the enlarged mass and defects in orbital roof and lesser and greater wings of the sphenoid bone. The surgical excision of the right eyelid lesion was performed.
Biopsy
;
Brain
;
Child
;
Exophthalmos
;
Eyelids*
;
Female
;
Humans
;
Hypertrophy
;
Neurofibroma, Plexiform*
;
Neurofibromatoses*
;
Orbit*
;
Parturition
;
Skin
;
Skull
;
Sphenoid Bone
5.Erratum: Population Pharmacokinetic Analysis of Metformin Administered as Fixed-Dose Combination in Korean Healthy Adults
Suein CHOI ; Sangil JEON ; Seunghoon HAN ; Dong Seok YIM
Translational and Clinical Pharmacology 2018;26(3):143-143
In the published version of this article, the contents of Table 1 (‘Demographic characteristics of subjects’) are incorrect.
6.Anglographic Findings of Collateral Vessels in Cervicofacial Vascular Lesions with Previously Ligated Carotid Artery.
Moon Hee HAN ; Kee Hyun CHANG ; Dong Gyu NA ; Gi Seok HAN ; Kung Mo YEON
Journal of the Korean Radiological Society 1995;32(1):1-7
PURPOSE: The purpose of this study is to describe the anglographic findings of collateral vessels in cervicofacial vascular lesions with previously ligated carotid arteries and to evaluate the extent of anglographic assessmant needed before embolization. MATERIALS AND METHODS: We retrospectively reviewed 10 cervicofacial vascular lesions with previously ligated carotid artery, which were 6 cases of arteriovenous malformation, 2 cases of carotid cavernous fistula, 1 case of hemangioma and 1 case of arteriovenous realformation with carotid cavernous fistula. The previously ligated arteries are proximal external carotid artery (n=5), branches of external carotid artery (n=2) and common carotid artery (n=3). Common carotid artery or internal carotid artery (n=9), vertebral artery (n=5), ipsilateral external carotid artery (n=4), contralateral external carotid artery (n=5), costocervical trunk (n=2), thyrocervical trunk (n=2) were assessed by conventional angiography. Angiography of both carotid and vertebral arteries was performed in 5 cases. RESULTS: The collateral vascular channels were inferolateral trunk of internal carotid artery (n=8), vertebral artery (n=5), contralateral external carotid artery (n=5), ipsilateral external carotid artery (n=4), deep cervical artery (n=2) and ascending cervical artery (n=l). Embolizations were performed in 9 cases with operative cannulation(n=4), embolization via collateral branches of ipsilateral external carotid artery (n=l), embolization via collateral branches of contralateral external carotid artery (n=3) and balloon occulusion via direct puncture (n=l). CONCLUSION: The collateral channels in cervicofacial vascular lesions with previouly ligated carotid artery were inferolateral trunk of internal carotid artery, contralateral or ipsilateral external carotid artery, vertebral artery, deep cervical artery and ascending cervical artery on angiography. Complete anglographic assessment of possible collateral channels is mandatory for the effective and safe embolization.
Angiography
;
Arteries
;
Arteriovenous Malformations
;
Carotid Arteries*
;
Carotid Artery, Common
;
Carotid Artery, External
;
Carotid Artery, Internal
;
Fistula
;
Hemangioma
;
Punctures
;
Retrospective Studies
;
Vertebral Artery
7.A case of successfully resected retroperitoneal hemangiopericytoma.
Il Jung CHOI ; Myoung Seok HAN ; Moon Seok CHA
Korean Journal of Obstetrics and Gynecology 2009;52(7):771-775
Hemangiopericytoma is a rare mesenchymal neoplasm, accounting for about 1% of vascular tumor. Hemangiopericytoma is known to be derived from the vascular pericyte and occurs most commonly lower extremities, pelvis and retroperitoneum. Surgical radical excision is the treatment of choice. Because of malignant features of hemangiopericytoma, long term and close follow-up is important. We report a case of successfully resected retroperitoneal hemangiopericytoma.
Accounting
;
Follow-Up Studies
;
Hemangiopericytoma
;
Lower Extremity
;
Pelvis
;
Pericytes
8.A Case of Acneiform Eruption Induced by Bevacizumab
Seok Hyun HAN ; Ji Hyun KIM ; Yong Woo OH ; Dong Hee KIM ; Yu Sung CHOI ; Ho Seok SUH
Korean Journal of Dermatology 2019;57(3):159-161
No abstract available.
Acneiform Eruptions
;
Bevacizumab
9.Current state of clinical trials in Korea.
Journal of the Korean Medical Association 2010;53(9):745-752
The number of clinical trials sponsored by global pharmaceutical companies performed in countries other than the U.S. and Western Europe has been steadily increasing over the past decade. Among those emerging countries, Korea deserves attention for its rapid growth in the number of trials and sites. As of 2009, Korea was ranked the tenth country in the number of clinical trials registered at http://clinicaltrials.gov. This is remarkable growth given that it was not included in the top 30 countries in 2005. High population density, qualified medical professionals, regulatory changes including Investigational New Drug-New Drug Application (IND/NDA) separation, acceptance of International Conferences on Harmonization-Good Clinical Practices (ICH-GCP) by Korea Food&Drug Administration (KFDA), and governmental policies to boost clinical trials were the most influential factors that caused such an outstanding achievement. The Korean National Enterprise for Clinical Trials (KoNECT), an organization founded to lead initiatives to improve the milieu for clinical trials, has been playing a pivotal role in the steering of 15 regional clinical centers designated by the government. Based upon improvements in infrastructure so far, diversity in therapeutic areas and the proportion of early phase trials are expected to grow. Korea has grown to be one of the major countries in the clinical trial market, which was made possible by the cooperation of industry, academia and government. Further investment and efforts to solve current challenges will allow such growth to continue into the next decade.
Achievement
;
Congresses as Topic
;
Europe
;
Investments
;
Korea
;
Population Density
10.Comparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients.
Yoon Seok KIM ; Dong Won RYU ; Chung Han LEE
Kosin Medical Journal 2016;31(1):19-29
OBJECTIVES: Breast conserving surgery (BCS) for early breast cancer is now an accepted treatment, but there are controversies about its comparability with mastectomy. Thus, we investigated the survival outcomes who underwent BCS and modified radical mastectomy (MRM). METHODS: In this retrospective review, we analyzed the survival outcomes of 618 patients with early breast cancer who underwent two different surgery from January 2002 to December 2009. Postoperative pathologic difference, disease free survival period, overall survival period, recurrence pattern, recurrent rate and site were compared. In addition, preoperative patients data are also collected. RESULTS: Disease free survival period of MRM and BCS was 108.46 months and 80.82 months, respectively (P < 0.01). However, there was no significant correlation between overall survival period and operative methods (P = 0.67). In addition, recurrence pattern (P = 0.21), recurrent rate (P = 0.36) and site (P = 0.45, P = 0.09) were not associated with operative method. CONCLUSIONS: In this study, we can suggest that early breast cancer patients could improve their disease free survival if they underwent MRM. So, when we operate high risk breast cancer patients, MRM could be considered for their disease free life. Further studies may be required to establish appropriate strategy of surgery for early breast cancer.
Breast Neoplasms*
;
Breast*
;
Disease-Free Survival
;
Humans
;
Mastectomy
;
Mastectomy, Modified Radical*
;
Mastectomy, Segmental*
;
Methods
;
Recurrence
;
Retrospective Studies